Cargando…
Aminoglycoside Antibiotics Inhibit Mycobacteriophage Infection
Antibiotic resistance is becoming the biggest threat to global health. At the same time, phage therapy is witnessing a return of interest. The therapeutic use of bacteriophages that infect and kill bacteria is a suitable strategy to combat antibiotic resistance. Furthermore, bacteriophages are incre...
Autores principales: | Jiang, Zheng, Wei, Junwei, Liang, Yunxiang, Peng, Nan, Li, Yingjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603143/ https://www.ncbi.nlm.nih.gov/pubmed/33086520 http://dx.doi.org/10.3390/antibiotics9100714 |
Ejemplares similares
-
Aminoglycoside Antibiotics Inhibit Phage Infection by Blocking an Early Step of the Infection Cycle
por: Kever, Larissa, et al.
Publicado: (2022) -
Mechanistic insights into translation inhibition by aminoglycoside antibiotic arbekacin
por: Parajuli, Narayan Prasad, et al.
Publicado: (2021) -
Advances in the Application of Aptamer Biosensors to the Detection of Aminoglycoside Antibiotics
por: Luan, Yunxia, et al.
Publicado: (2020) -
Ototoxicity of Non-aminoglycoside Antibiotics
por: Rybak, Leonard P., et al.
Publicado: (2021) -
Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections
por: Ouyang, Xudong, et al.
Publicado: (2023)